14 reports

  • COMPANION DIAGNOSTIC ASSAY - COXIBS AND NSAIDS
  • COMPANION DIAGNOSTIC ASSAY - COXIBS AND NSAIDS PRODUCT OVERVIEW

one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Anti Rheumatic
  • Biomarker
  • Chronic Disease
  • Immunodiagnostics
  • Firalis SAS

Competitive Landscape ##. ## Abbvie ##. ## Biogen Idec ##. ## Bristol-Myers Squibb ##. ## Celgene ##. ## Celltrion ##. ## J& J ##. ## MedImmune ##. ## Merck ##. ## Novartis ##. ## Takeda List of Figures Figure ##-##: Representation of the Disease Progression in Rheumatoid Arthritis Figure ##-

  • Anti Rheumatic
  • Arthritis
  • Medical Biotechnology
  • Therapy
  • World

In more severe cases disease modifying anti-rheumatic drugs (DMARDs) may be prescribed.

  • Anti Rheumatic
  • Medical Biotechnology
  • Therapy
  • United States
  • World

In moderate to severe cases the treatment involves disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (Rheumatrex®).

  • Anti Rheumatic
  • Medical Biotechnology
  • Therapy
  • United States
  • World

The initial treatment option is disease-modifying antirheumatic drugs, also known as DMARDs.

  • Anti Rheumatic
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Anti Rheumatic
  • Monoclonal Antibody
  • Pain Relief
  • World
  • Product Initiative
  • JAN 17, 2017: OXFORD PHARMASCIENCE GROUP: TECHNICAL, CLINICAL AND REGULATORY UPDATE

Ketorolac is an NSAID in the family of heterocyclic acetic acid derivatives which is used for moderate-to-severe pain, often prescribed in place of opioids.

  • Anti Rheumatic
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • JAN 17, 2017: OXFORD PHARMASCIENCE GROUP: TECHNICAL, CLINICAL AND REGULATORY UPDATE

Ketorolac is an NSAID in the family of heterocyclic acetic acid derivatives which is used for moderate-to-severe pain, often prescribed in place of opioids.

  • Anti Rheumatic
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company

INTRODUCTION.............. ## ##.

  • Anti Rheumatic
  • United States
  • World
  • Demand
  • Market Shares

Orencia may be used as monotherapy or concomitantly with diseasemodifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists.

  • Anti Rheumatic
  • Arthritis
  • Medical Biotechnology
  • Monoclonal Antibody
  • Pfizer Inc.
  • sarilumab - Drug Profile
  • golimumab - Drug Profile

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Anti Rheumatic
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • 4.1 Changes to Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs, 2015-2022
  • inadequate responses or intolerance to these treatments (Hyrich et al., 2007). These patients

Arthritis Care and Research; ##(##): ##-## Smolen JS, et al. (2013) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

  • Anti Rheumatic
  • Therapy

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Arthritis
  • Clinical Trial
  • Pharmaceutical
  • World
  • IBUPROFEN - DRUG PROFILE
  • ECP-1014 - DRUG PROFILE

Meloxicam is an oxicam derivative.

  • Anti Rheumatic
  • Chronic Disease
  • United States
  • Company
  • Product Initiative